Chapter 5: Circulatory Pathology
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Circulatory Pathology distinguishes between protein-poor transudates and protein-rich exudates, alongside specific conditions like anasarca. The text then transitions to hemostasis, detailing the complex interaction between the vascular wall, platelets, and the coagulation cascade to form a stable fibrin-platelet plug. This section thoroughly breaks down platelet function—from adhesion mediated by von Willebrand factor and Glycoprotein Ib to aggregation involving Glycoprotein IIb-IIIa—and contrasts qualitative platelet defects (such as Bernard-Soulier syndrome and Glanzmann thrombasthenia) with quantitative disorders like Immune Thrombocytopenic Purpura (ITP), Thrombotic Thrombocytopenic Purpura (TTP), and Hemolytic Uremic Syndrome (HUS). Significant attention is given to the coagulation cascade, differentiating the intrinsic pathway (monitored by PTT) from the extrinsic pathway (monitored by PT/INR), and discussing major bleeding disorders including Hemophilia A and B, Vitamin K deficiency, and the widespread consumption coagulopathy known as Disseminated Intravascular Coagulation (DIC). The chapter further explores thrombosis through the lens of Virchow's triad—endothelial injury, abnormal blood flow, and hypercoagulability—and tracks the potential outcomes of thrombi, such as resolution, organization, or embolization. The concept of embolism is expanded to cover various types, including pulmonary emboli originating from deep vein thrombosis (DVT), fat emboli from trauma, and amniotic fluid emboli. The text also explains infarction, classifying infarcts as either hemorrhagic (red) in organs with dual blood supply or anemic (white) in solid organs with end-arterial circulation. Finally, the chapter concludes with a comprehensive review of shock, outlining the stages of compensation and decompensation, and categorizing the major etiologies into cardiogenic, hypovolemic, septic, neurogenic, and anaphylactic shock, noting the ultimate risks of irreversible tissue injury and multi-organ failure.